Back to AVTX
Caligan Partners LP AVTX Position History
Avalo Therapeutics, Inc. • Healthcare
Quarters held
4
Latest value
$50.1M
Q3 2026
Peak value
$58.5M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $16M |
| Q1 2026 | $24.4M |
| Q2 2026 | $58.5M |
| Q3 2026 | $50.1M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $50.1M | 3.27M | — | — |
| Q2 2026 | $58.5M | 3.16M | — | — |
| Q1 2026 | $24.4M | 1.64M | — | — |
| Q4 2025 | $16M | 881.5K | — | — |
Other funds holding AVTX
$66.7M
$64.2M
$59M
$55.3M
$53.4M